Elanco · 2 weeks ago
Assistant General Counsel, Corporate Transactions & Business Development
Elanco is a global leader in animal health dedicated to innovation and delivering products and services for farm animals and pets. The Assistant General Counsel will support business development and key functions, focusing on complex domestic and international agreements and transactions while leveraging AI tools for process improvements.
ManufacturingPetSupply Chain Management
Responsibilities
Provide legal counsel on business development, commercial, and general corporate laws inclusive of contract law, regulatory frameworks relevant to a global business
Work with business development and other partners to successfully execute asset divestitures, strategic partnerships and other corporate transactions on a worldwide basis, ensuring transactions are consistent with business strategies and reflect appropriate legal risk positions
As a critical member of a cross-functional deal team, work on legal due diligence, develop and negotiate key deal terms, draft asset purchase and other agreements of varying complexity, ensure compliance with regulatory and other requirements, and manage post-closing integration and other activities
Advise on various finance, tax and treasury related initiatives
Leverage thought leadership and external networks to conduct training and other professional development activities for Elanco’s global legal and business development organizations, ensuring continued understanding of material developments related to corporate and transactional law
Assist with the selection and engagement of outside counsel to provide critical support on complex legal, regulatory, and business issues
Collaborate with and create business solutions with other members of both legal and business teams to mitigate risk to Elanco, optimize service levels, and minimize the utilization of outside counsel where practicable
Leverage legal expertise and business acumen to support Elanco in achieving its objectives
Support the identification of process improvements and the development and implementation a comprehensive strategy for systematically optimizing how the business development and overall legal team works including, but not limited to the use of technology, AI, development of internal workflows, processes, and playbooks
Collaborate with cross-functional teams to address legal issues in new and existing initiatives with an eye towards automation through technological advancements and opportunities to insource legal work
Qualification
Required
Education: Juris Doctor (JD) degree from an accredited law school; admission to at least one U.S. state bar
Experience: A minimum of 5 years of experience in business development, corporate law, preferably in a corporate or law firm setting – significant experience drafting, negotiating and executing (multi-jurisdictional) deals
Top Skills: Strong understanding of business development and general corporate law; demonstrated ability to handle multiple projects in a complex, fast-paced environment and exercise sound legal judgement and capable of providing legal and strategic guidance to senior management and functional organizational leadership
Preferred
Experience in the animal health or pharmaceutical industry
Familiarity leading and executing fast paced business development deals with business acumen
Excellent interpersonal, strategic thinking, communication, and organizational skills and innovative hands-on problem-solving mentality
Strong ability to develop visual ideas and communicate messaging and guidance to senior leaders with a dedicated following
Familiarity with specialized subjects that arise in transactional matters, including securities laws, tax, IP, antitrust, employment, finance, data privacy, regulatory and technology
Familiarity with the utilization of technology including AI in a legal team
Company
Elanco
Elanco is an animal health company that manufactures and markets a diverse range of products to promote animal health and well-being.
Funding
Current Stage
Public CompanyTotal Funding
$252.86MKey Investors
AncoraBill & Melinda Gates Foundation
2023-12-30Post Ipo Equity· $250M
2018-09-19IPO
2017-05-24Grant· $2.86M
Leadership Team
Recent News
2026-01-03
2025-12-18
Company data provided by crunchbase